CZ307452B6 - Aminooxylipidy pro konstrukci samoskladných liposomálních systémů umožňujících jejich následnou modifikaci biologicky funkčními molekulami - Google Patents
Aminooxylipidy pro konstrukci samoskladných liposomálních systémů umožňujících jejich následnou modifikaci biologicky funkčními molekulamiInfo
- Publication number
- CZ307452B6 CZ307452B6 CZ2016-685A CZ2016685A CZ307452B6 CZ 307452 B6 CZ307452 B6 CZ 307452B6 CZ 2016685 A CZ2016685 A CZ 2016685A CZ 307452 B6 CZ307452 B6 CZ 307452B6
- Authority
- CZ
- Czechia
- Prior art keywords
- general formula
- aminooxylipids
- butoxycarbonyl
- construction
- self
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
- C07C239/08—Hydroxylamino compounds or their ethers or esters
- C07C239/20—Hydroxylamino compounds or their ethers or esters having oxygen atoms of hydroxylamino groups etherified
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
- A61K47/6913—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome the liposome being modified on its surface by an antibody
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Abstract
Nové aminooxylipidy obecného vzorce I, kde n= 5 až 30 a X je polymethylenová spojka obecného vzorce II, kde n= 2 až 10, nebo polyethylenglykolová spojka obecného vzorce III, kde n= 1 až 14. Způsob přípravy aminooxylipidů obecného vzorce I, vyznačující se tím, že acylacíbutoxykarbonyl-polymethylendiaminu, či-butoxykarbonyl-polyethyleglykoldiaminu symetricky v poloze C(2) větvenou mastnou kyselinou obecného vzorce IV, v přítomnosti kondenzačního činidla nebo od kyseliny I odvozeným acylchloridem obecného vzorce V, se připraví-Boc-aminolipidy obecného vzorce VI. Ty se převedou na aminolipidy obecného vzorce VII. Jejich kondenzací s kyselinou-butoxykarbonylaminooxyoctovou v přítomnosti kondenzačního činidla se získajíBoc-aminooxylipidy obecného vzorce VIII, které debocylací poskytnou aminooxylipidy obecného vzorce I. Acylchloridy obecného vzorce V se připraví reakcí kyselin obecného vzorce IV s oxalylchloridem v přítomnosti katalytického množství-dimethylformamidu v organickém aprotickém rozpouštědle. Použití netoxických aminooxylipidů obecného vzorce I pro konstrukci netoxických samoskladných liposomálních nosičů léčiv prezentujících aminooxyskupiny a takzvaná "postliposomální" modifikace těchto nosičů biologicky funkčními molekulami za použití oximové ligační techniky.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ2016-685A CZ307452B6 (cs) | 2016-11-03 | 2016-11-03 | Aminooxylipidy pro konstrukci samoskladných liposomálních systémů umožňujících jejich následnou modifikaci biologicky funkčními molekulami |
US16/336,844 US11492327B2 (en) | 2016-11-03 | 2017-11-02 | Aminooxylipids for the construction of self-assembling liposomal systems enabling their subsequent modification by biologically functional molecules |
CA3039404A CA3039404C (en) | 2016-11-03 | 2017-11-02 | Aminooxylipids for construction of self-assembling liposomal systems enabling their subsequent modification by biologically functional molecules |
PCT/CZ2017/050054 WO2018082723A1 (en) | 2016-11-03 | 2017-11-02 | Aminooxylipids for the construction of self-assembling liposomal systems enabling their subsequent modification by biologically functional molecules |
EP17832461.2A EP3535238B1 (en) | 2016-11-03 | 2017-11-02 | Aminooxylipids for the construction of self-assembling liposomal systems enabling their subsequent modification by biologically functional molecules |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ2016-685A CZ307452B6 (cs) | 2016-11-03 | 2016-11-03 | Aminooxylipidy pro konstrukci samoskladných liposomálních systémů umožňujících jejich následnou modifikaci biologicky funkčními molekulami |
Publications (2)
Publication Number | Publication Date |
---|---|
CZ2016685A3 CZ2016685A3 (cs) | 2018-05-16 |
CZ307452B6 true CZ307452B6 (cs) | 2018-09-05 |
Family
ID=61007406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CZ2016-685A CZ307452B6 (cs) | 2016-11-03 | 2016-11-03 | Aminooxylipidy pro konstrukci samoskladných liposomálních systémů umožňujících jejich následnou modifikaci biologicky funkčními molekulami |
Country Status (5)
Country | Link |
---|---|
US (1) | US11492327B2 (cs) |
EP (1) | EP3535238B1 (cs) |
CA (1) | CA3039404C (cs) |
CZ (1) | CZ307452B6 (cs) |
WO (1) | WO2018082723A1 (cs) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002048170A1 (en) * | 2000-12-12 | 2002-06-20 | Mitsubishi Chemical Corporation | Lipids comprising an aminoxy group |
WO2006016097A2 (en) * | 2004-08-13 | 2006-02-16 | Ic Vec Limited | Vector comprising polymer modified sirna liposomes |
US20120220668A1 (en) * | 2011-02-24 | 2012-08-30 | Dennis Bong | Membrane stabilizing compositions and methods |
WO2013104346A1 (en) * | 2012-01-13 | 2013-07-18 | Ustav Organicke Chemie A Biochemie Av Cr, V.V.I. | Lipopolyamines of spermine type for construction of liposomal transfection systems |
US20130302891A1 (en) * | 2012-05-10 | 2013-11-14 | Muhammad Naveed Yousaf | Compositions and methods for promoting liposomal and cellular adhesion |
WO2013181697A1 (en) * | 2012-06-05 | 2013-12-12 | The University Of Melbourne | Bicyclo[6.1.0]non-4-yne compounds suitable for use as linkers in biological applications |
WO2014197991A1 (en) * | 2013-06-12 | 2014-12-18 | Muhammad Yousaf | Compounds for promoting liposomal and cellular adhesion and compositions and methods of use thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050287202A1 (en) | 2000-12-12 | 2005-12-29 | Miller Andrew D | Compound |
-
2016
- 2016-11-03 CZ CZ2016-685A patent/CZ307452B6/cs unknown
-
2017
- 2017-11-02 EP EP17832461.2A patent/EP3535238B1/en active Active
- 2017-11-02 US US16/336,844 patent/US11492327B2/en active Active
- 2017-11-02 CA CA3039404A patent/CA3039404C/en active Active
- 2017-11-02 WO PCT/CZ2017/050054 patent/WO2018082723A1/en unknown
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002048170A1 (en) * | 2000-12-12 | 2002-06-20 | Mitsubishi Chemical Corporation | Lipids comprising an aminoxy group |
WO2006016097A2 (en) * | 2004-08-13 | 2006-02-16 | Ic Vec Limited | Vector comprising polymer modified sirna liposomes |
US20120220668A1 (en) * | 2011-02-24 | 2012-08-30 | Dennis Bong | Membrane stabilizing compositions and methods |
WO2013104346A1 (en) * | 2012-01-13 | 2013-07-18 | Ustav Organicke Chemie A Biochemie Av Cr, V.V.I. | Lipopolyamines of spermine type for construction of liposomal transfection systems |
US20130302891A1 (en) * | 2012-05-10 | 2013-11-14 | Muhammad Naveed Yousaf | Compositions and methods for promoting liposomal and cellular adhesion |
WO2013181697A1 (en) * | 2012-06-05 | 2013-12-12 | The University Of Melbourne | Bicyclo[6.1.0]non-4-yne compounds suitable for use as linkers in biological applications |
WO2014197991A1 (en) * | 2013-06-12 | 2014-12-18 | Muhammad Yousaf | Compounds for promoting liposomal and cellular adhesion and compositions and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
CZ2016685A3 (cs) | 2018-05-16 |
WO2018082723A1 (en) | 2018-05-11 |
EP3535238B1 (en) | 2021-04-21 |
US20210292275A1 (en) | 2021-09-23 |
CA3039404A1 (en) | 2018-05-11 |
EP3535238A1 (en) | 2019-09-11 |
US11492327B2 (en) | 2022-11-08 |
CA3039404C (en) | 2021-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20190878T1 (hr) | Modificirane aminokiseline koje sadrže azidnu grupu | |
US10301276B2 (en) | Method of producing furan carboxylates from aldaric acids by using solid heterogeneous catalyst | |
RU2020105707A (ru) | Алкоксилированные сложные эфирамины и их соли | |
Shinada et al. | An efficient synthesis of α-acyloxyketone by Cu (acac) 2-catalyzed insertion reaction of α-diazoketone to carboxylic acid | |
DE60312696D1 (de) | Carbamat-funktionelles polyesterharz, ein verfahren zur herstellung dieses harzes und beschichtungszusammensetzung davon | |
MX356028B (es) | Compuesto adyuvante. | |
CN103958568B (zh) | 通过均相催化醇胺化制备亲油性聚亚烷基多胺 | |
Hunter et al. | Total synthesis of unguisin A | |
CA2991011C (en) | Method for producing hetero type monodispersed polyethylene glycol | |
CN103896872A (zh) | 米拉贝隆的合成方法 | |
EP3747891A3 (en) | Compositions and methods for conjugating oligonucleotides | |
HRP20210121T1 (hr) | Konjugati nativnog omv-antigena i njihova upotreba | |
CZ307452B6 (cs) | Aminooxylipidy pro konstrukci samoskladných liposomálních systémů umožňujících jejich následnou modifikaci biologicky funkčními molekulami | |
EP1988095A3 (de) | Verfarhen zur Herstellung von Aminoaryl- bzw. heteroarylboronsaeuren und ihren Derivaten | |
CN108635590B (zh) | 一种pH响应的多糖–硼替佐米纳米球及其制备方法和应用 | |
SI2580189T1 (en) | Intermediates of agomelatine and the procedure for their preparation | |
WO2013036623A3 (en) | Anti-foaming agents for hot-melt adhesives | |
JP2012502162A5 (cs) | ||
Soulère et al. | An expeditious synthesis of 4-hydroxy-2 (E)-nonenal (4-HNE), its dimethyl acetal and of related compounds | |
JP2022527404A (ja) | 10-メチレン脂質の誘導体、そのような誘導体の調製方法、およびその使用方法 | |
CN106008540A (zh) | 有抗肿瘤活性的芳香杂环酸酯类鬼臼毒素衍生物及制备方法与应用 | |
Spiccia et al. | Cross-Metathesis of Brønsted Acid Masked Alkenylamines with Acrylates for the Synthesis of Polyamide Monomers | |
RU2010102070A (ru) | Способ получения фторамида и фторнитрила | |
Kim et al. | Enantiomeric recognition of d-and l-amino acid methyl ester hydrochlorides by new chiral bis-pyridino-18-crown-6 substituted with urea, and diphenyl groups | |
Babič et al. | Epoxide opening with amino acids: improved synthesis of hydroxyethylamine dipeptide isosteres |